Skip to main content

Advertisement

SpringerLink
Log in

Imaging Protocols for Active Surveillance in Renal Cell Carcinoma

  • New Imaging Techniques (S Rais-Bahrami and K Porter, Section Editors)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

To review the growth kinetics of small renal masses and available imaging modalities for mass characterization and surveillance, highlight current organizational recommendations for the active surveillance of small renal masses, and discuss the most recently reported oncological outcomes of patients as they relate to various surveillance imaging protocols and progression to delayed intervention.

Recent Findings

Overall, organizational guideline recommendations are broad and lack specifics regarding timing and modality for follow-up imaging of small renal masses. Additionally, despite general consensus in the literature about certain criteria to trigger delayed intervention, there exist no formal guidelines.

Summary

Active surveillance of small renal masses is an acceptable management strategy for patients with prohibitive surgical risk; however, standardized imaging protocols for surveillance are lacking, as are randomized, prospective trials to evaluate the ideal follow-up protocol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Campbell SC, Novick AC, Belldegrun A, et al. Guideline for the management of the clinical T1 renal mass. J Urol. 2009;182(4):1271–9. This organizational guideline has one of the more comprehensive current recommendations and is the only guideline to recommend a trigger (growth rate) for delayed intervention.

    Article  PubMed  Google Scholar 

  2. •• Chawla SN, Crispen PL, Hanlon AL, et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425–31. This review provides insight into the natural history of small renal masses and helps to establish the relative safety of active surveillance. Overall, growth rate of these lesions is slow and metastatic and cancer-specific mortality is low.

    Article  PubMed  Google Scholar 

  3. Rothman J, Egleston B, Wong YN, Iffrig K, Lebovitch S, Uzzo RG. Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. J Urol. 2009;181:29–33.

    Article  PubMed  Google Scholar 

  4. Frank I, Blute ML, Cheville JC, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217–20.

    Article  PubMed  Google Scholar 

  5. Kunkle DA, Crispen PL, Li T, Uzzo RG. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol. 2007;177:1692–6.

    Article  PubMed  Google Scholar 

  6. Thompson RH, Kurta JM, Kaag M, Tickoo SK, Kundu S, Katz D, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol. 2009;181:2033–6.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Mason RJ, Abdolell M, Trottier G, Pringle C, Lawen JG, Bell DG, et al. Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance. Eur Urol. 2011;59(5):863–7.

    Article  PubMed  Google Scholar 

  8. Kunkle DA, Chen DY, Greenberg RE, et al. Metastatic progression of enhancing renal masses under active surveillance is associated with rapid interval growth of the primary tumor. J Urol. 2008;179(Suppl. 4):375.

    Article  Google Scholar 

  9. Smaldone MC, Kutikov A, Egleston BL, Canter DJ, Viterbo R, Chen DYT, et al. Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer. 2012;118:997–1006.

    Article  PubMed  Google Scholar 

  10. Li XS, Yao L, Gong K, Yu W, He Q, Zhou LQ, et al. Growth pattern of renal cell carcinoma (RCC) in patients with delayed surgical intervention. J Cancer Res Clin Oncol. 2012;138:269–74.

    Article  PubMed  Google Scholar 

  11. Zhang L, Yin W, Yao L, et al. Growth pattern of clear cell renal cell carcinoma in patients with delayed surgical intervention: fast growth rate correlates with high grade and may result in poor prognosis. Biomed Res Int. 2015;2015:598134.

    PubMed  PubMed Central  Google Scholar 

  12. Mehrazin R, Smaldone MC, Egleston B, et al. Is anatomic complexity associated with renal tumor growth kinetics under active surveillance?, Urol Oncol. 2015;33(4):167.e7–12.

  13. Pierorazio PM, Johnson MH, Ball MW, Gorin MA, Trock BJ, Chang P, et al. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. Eur Urol. 2015;68(3):408–15.

    Article  PubMed  Google Scholar 

  14. Gupta M, Blute ML, Su LM, Crispen PL. Delayed intervention of small renal masses on active surveillance. J Kidney Cancer VHL. 2017;4(2):24–30.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Park SW, Lee SS, Lee DH, Nam JK, Chung MK. Growth kinetics of small renal mass: initial analysis of active surveillance registry. Investig Clin Urol. 2017;58(6):429–33.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Beisland C, Hjelle KM, Reisaeter LAR, Bostad L. Observation should be considered as an alternative in management of renal masses in older and comorbid patients. Eur Urol. 2009;55:1419–29.

    Article  PubMed  Google Scholar 

  17. Rosales JC, Haramis G, Moreno J, Badani K, Benson MC, McKiernan J, et al. Active surveillance for renal cortical neoplasms. J Urol. 2010;183:1698–702.

    Article  PubMed  Google Scholar 

  18. Crispen PL, Viterbo R, Fox EB, Greenberg RE, Chen DYT, Uzzo RG. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer. 2008;112:1051–7.

    Article  PubMed  Google Scholar 

  19. Kunkle DA, Crispen PL, Chen DY, et al. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007;177:849–53.

    Article  PubMed  Google Scholar 

  20. Uzosike AC, Patel HD, Alam R, Schwen ZR, Gupta M, Gorin MA, et al. Growth kinetics of small renal masses on active surveillance: variability and results from the DISSRM registry. J Urol. 2018;199(3):641–8.

    Article  PubMed  Google Scholar 

  21. Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DYT, Uzzo RG. Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer. 2009;115:2844–52.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Israel GM, Casalino DD, Remer EM, et al. Appropriateness criteria: indeterminate renal masses. American College of Radiology: Reston; 2014. www.guideline.gov/summaries/summary/48291 [Accessed May 2018]

    Google Scholar 

  23. Krishna S, Murray CA, McInnes MD, et al. CT imaging of solid renal masses: pitfalls and solutions. Clin Radiol. 2017;72:708–21.

    Article  PubMed  CAS  Google Scholar 

  24. Ramamurthy NK, Moosavi B, McInnes MDF, et al. Multiparametric MRI of solid renal masses: pearls and pitfalls. Clin Radiol. 2015;70:304–16.

    Article  PubMed  CAS  Google Scholar 

  25. ACR Manual on Contrast Media. American College of Radiology. Veresion 10.3. https://www.acr.org/Clinical-Resources/Contrast-Manual [Accessed July 2018].

  26. Sun MRM, Ngo L, Genega EM, Atkins MB, Finn ME, Rofsky NM, et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes - correlation with pathologic findings. Radiology. 2009;250:793–802.

    Article  PubMed  Google Scholar 

  27. Pedrosa I, Chou MT, Ngo L, H. Baroni R, Genega EM, Galaburda L, et al. MR classification of renal masses with pathologic correlation. Eur Radiol. 2008;18(2):365–75.

    Article  PubMed  Google Scholar 

  28. Bata P, Gyebnar J, Tarnoki DL, Tarnoki AD, Kekesi D, Szendroi A, et al. Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT. Diagn Interv Radiol. 2013;19(5):387–92.

    PubMed  Google Scholar 

  29. Millet I, Doyon FC, Hoa D, Thuret R, Merigeaud S, Serre I, et al. Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? AJR Am J Roentgenol. 2011;197:887–96.

    Article  PubMed  Google Scholar 

  30. Egbert ND, Caoili EM, Cohan RH, Davenport MS, Francis IR, Kunju LP, et al. Differentiation of papillary renal cell carcinoma subtypes on CT and MRI. AJR Am J Roentgenol. 2013;201:347–55.

    Article  PubMed  Google Scholar 

  31. Gorin MA, Rowe SP, Allaf ME. Nuclear imaging of renal tumours: a step towards improved risk stratification. Nat Rev Urol. 2015;12:445–50.

    Article  PubMed  Google Scholar 

  32. Farber NJ, Wu Y, Zou L, et al. Challenges in RCC imaging: renal insufficiency, post-operative surveillance, and the role of radiomics. Kidney Cancer J. 2015;13:84.

    PubMed  PubMed Central  Google Scholar 

  33. James K, Eisenhauer E, Christian M, Terenziani M, Vena D, Muldal A, et al. Measure response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst. 1999;91:523–8.

    Article  PubMed  CAS  Google Scholar 

  34. Punnen S, Haider MA, Lockwood G, Moulding F, O’Malley ME, Jewett MAS. Variability in size measurement of renal masses smaller than 4 cm on computerized tomography. J Urol. 2006;176:2386–90.

    Article  PubMed  Google Scholar 

  35. Dachman AH, MacEneaney PM, Adedipe A, et al. Tumor size on computed tomography scans: is one measurement enough? Cancer. 2001;91:555–60.

    Article  PubMed  CAS  Google Scholar 

  36. NCCN Clinical practice guidelines in oncology, kidney Cancer, version 2.2016. National Comprehensive Cancer Network.

  37. Mucksavage P, Kutikov A, Magerfleisch L, van Arsdalen K, Wein AJ, Ramchandani P, et al. Comparison of radiographical imaging modalities for measuring the diameter of renal masses: is there a sizeable difference? BJU Int. 2011;108(8 Pt 2):E232–6.

    Article  PubMed  Google Scholar 

  38. Finelli A, Ismaila N, Bro B, et al. Management of small renal masses: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35(6):668–80.

    Article  PubMed  Google Scholar 

  39. Ljungberg B, Albiges L, Bensalah K, et al. Renal cell carcinoma guidelines. European Association of Urology http://uroweb.org/guideline/renal-cell-carcinoma. [Accessed May 2018].

  40. Jewett MAS, Rendon R, Lacombe L, et al. Canadian guidelines for the management of small renal masses (SRM). Can Urol Assoc J. 2015;9(5–6):160–3.

    Article  PubMed  PubMed Central  Google Scholar 

  41. McIntosh AG, Ristau BT, Ruth K, et al. Active surveillance for localized renal masses: tumor growth, delayed intervention rates, and >5-yr clinical outcomes. Eur Urol 2018 3, S0302–2838(18)30187-8.

  42. Jewett MA, Mattar K, Basiuk J, et al. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol. 2011;60:39–44.

    Article  PubMed  Google Scholar 

  43. Mehrazin R, Smaldone MC, Kutikov A, et al. Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol. 2014;192(3):659–64.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology at the Icahn School of Medicine at Mount Sinai, 1 Gustave Levy Place, New York, NY, 10029, USA

    Christine W. Liaw, Jared S. Winoker & Reza Mehrazin

Authors
  1. Christine W. Liaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jared S. Winoker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Reza Mehrazin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reza Mehrazin.

Ethics declarations

Conflict of Interest

Christine W. Liaw, Jared S. Winoker, and Reza Mehrazin each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on New Imaging Techniques

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liaw, C.W., Winoker, J.S. & Mehrazin, R. Imaging Protocols for Active Surveillance in Renal Cell Carcinoma. Curr Urol Rep 19, 81 (2018). https://doi.org/10.1007/s11934-018-0830-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11934-018-0830-z

Keywords

Search

Navigation